Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07834)

• Formulation Name: Ezogabine 300 mg tablet
• Company: GlaxoSmithKline

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Retigabine	(DMGNYIH)	Behcet disease	4A62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Soybean lecithin	(E00637)	Not Available	Other agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent